| Ident. | Authors (with country if any) | Title |
|---|
| 000A28 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000A37 (2014) |
Asha Kishore [Inde] ; Traian Popa [France] ; Ammu Balachandran [Inde] ; Shyambabu Chandran [Inde] ; Salini Pradeep [Inde] ; Febina Backer [Inde] ; Syam Krishnan [Inde] ; Sabine Meunier [France] | Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients. |
| 000A70 (2014) |
Michael Feyder [Suède] ; Erik Södersten [Suède, Danemark] ; Emanuela Santini [Suède] ; Vincent Vialou [États-Unis, France] ; Quincey C. Laplant [États-Unis] ; Emily L. Watts [États-Unis] ; Giada Spigolon [Suède] ; Klaus Hansen [Danemark] ; Jocelyne Caboche [France] ; Eric Nestler [États-Unis] ; Gilberto Fisone [Suède] | A role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and ΔFosB expression |
| 000C23 (2013) |
Khaled-Ezaheir Bennouar [France] ; Michelle A. Uberti ; Christophe Melon ; Maria D. Bacolod ; Hermogenes N. Jimenez ; Manuel Cajina ; Lydia Kerkerian-Le Goff ; Darío Doller ; Paolo Gubellini | Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. |
| 000C35 (2013) |
François Tison [France] ; Laurence Nègre-Pagès ; Wassilios G. Meissner ; Sandrine Dupouy ; Qin Li ; Marie-Laure Thiolat ; Thibaud Thiollier ; Monique Galitzky ; Fabienne Ory-Magne ; Agathe Milhet ; Laurent Marquine ; Umberto Spampinato ; Olivier Rascol ; Erwan Bezard | Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. |
| 000C44 (2013) |
M. Verdet [France] ; J. Nicolau ; R. Lefaucheur ; D. Maltête ; S. Derrey ; A. Daragon | Recurrent bilateral metatarsal "stress-and-insufficiency" fractures in a levodopa-treated young woman with Parkinson's disease. |
| 000C49 (2013) |
Anna Castrioto [France] ; Andrea Kistner ; Hélène Klinger ; Eugénie Lhommée ; Emmanuelle Schmitt ; Valérie Fraix ; Stephan Chabardès ; Patrick Mertens ; Jean-Louis Quesada ; Emmanuel Broussolle ; Pierre Pollak ; Stéphane C. Thobois ; Paul Krack | Psychostimulant effect of levodopa: reversing sensitisation is possible. |
| 000C71 (2013) |
Laetitia Barbin [France] ; Christophe Leux ; Paul Sauleau ; Claire Meyniel ; Jean-Michel Nguyen ; Yann Pereon ; Philippe Damier | Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia. |
| 000C94 (2013) |
M U Ferraye [France] ; C. Ardouin ; E. Lhommée ; V. Fraix ; P. Krack ; S. Chabardès ; E. Seigneuret ; A-L Benabid ; P. Pollak ; B. Debû | Levodopa-resistant freezing of gait and executive dysfunction in Parkinson's disease. |
| 000D20 (2013) |
Hélène Pouclet [France] ; Pascal Derkinderen ; Thibaud Lebouvier | Foot dystonia heralding levodopa-induced dyskinesias in Parkinson disease. |
| 000D73 (2013) |
Erwan Bézard [République populaire de Chine] ; Ana Mu Oz ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. |
| 000D99 (2013) |
Caroline Moreau [France] ; Arnaud Delval [France] ; Vincent Tiffreau [France] ; Luc Defebvre [France] ; Kathy Dujardin [France] ; Alain Duhamel [France] ; Gregory Petyt [France] ; Claude Hossein-Foucher [France] ; David Blum [France] ; Bernard Sablonnière [France] ; Susanna Schraen [France] ; Delphine Allorge [France] ; Alain Destée [France] ; Régis Bordet [France] ; David Devos [France] | Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study |
| 000E27 (2013) |
Erwan Bezard [France, République populaire de Chine] ; Elisabetta Tronci [Italie, Suède] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Gregory Porras [Royaume-Uni] ; Anders Björklund [Suède] ; Manolo Carta [Italie, Suède] | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia |
| 001062 (2012) |
Eugénie Lhommée [France] ; Hélène Klinger ; Stéphane Thobois ; Emmanuelle Schmitt ; Claire Ardouin ; Amélie Bichon ; Andrea Kistner ; Valérie Fraix ; Jing Xie ; Magaly Aya Kombo ; Stephan Chabardès ; Eric Seigneuret ; Alim-Louis Benabid ; Patrick Mertens ; Gustavo Polo ; Sebastien Carnicella ; Jean-Louis Quesada ; Jean-Luc Bosson ; Emmanuel Broussolle ; Pierre Pollak ; Paul Krack | Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. |
| 001089 (2012) |
O. Rascol [France] ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De Witte | Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. |
| 001090 (2012) |
Gregory Porras [France] ; Amandine Berthet [France] ; Benjamin Dehay [France] ; Qin Li [République populaire de Chine] ; Laurent Ladepeche [France] ; Elisabeth Normand [France] ; Sandra Dovero [France] ; Audrey Martinez [France] ; Evelyne Doudnikoff [France] ; Marie-Laure Martin-Négrier [France] ; Qin Chuan [République populaire de Chine] ; Bertrand Bloch [France] ; Daniel Choquet [France] ; Eric Boué-Grabot [France] ; Laurent Groc [France] ; Erwan Bezard [France, République populaire de Chine] | PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
|
| 001164 (2012) |
Sylvia Navailles [France] ; Philippe De Deurwaerdère | Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease. |
| 001389 (2012) |
P. De Deurwaerdere [France] ; S. Navailles [France] | What can we expect from the serotonergic side of L-DOPA? |
| 001723 (2011) |
O. Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
| 001E92 (2009) |
Clemence Simonin [France] ; M. Tir ; D. Devos ; A. Kreisler ; K. Dujardin ; J. Salleron ; A. Delval ; S. Blond ; L. Defebvre ; A. Destée ; P. Krystkowiak | Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. |
| 001F21 (2009) |
Alain Destée [France] ; Karin Rérat ; Isabelle Bourdeix | Is there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon Study. |
